
There are no clinically available treatments for cognitive impairments in bipolar disorder despite intense research interest into novel treatments and a pressing clinical need for cognition treatments to improve prognosis, enhance functional recovery and reduce societal costs. The lack of effective treatments is partially due to major methodological challenges in the field.


The objectives of the task force are therefore to create:
- For researchers: Guidance for the methodology and design of cognition trials in bipolar disorder based on the methodological lessons learnt from extant cognition trials.
- For clinicians: Clinical recommendations on how to address cognitive impairments in the clinical management of bipolar disorder.
- For patients: Patient booklet with information about the nature of cognitive impairments in bipolar disorder and a practical guide on how to facilitate cognitive capacity (sleep, alcohol, breaks, etc.) and for how to compensate for the cognitive problems in daily life.
Leads
Kamilla Miskowiak,
Denmark
Members of Task Force
Vicent Balanzá, Spain
Christopher Bowie, Canada
Kate Burdick, USA
Andre Carvalho, Canada
Caterina del Mar Bonnin, Spain
Annemiek Dols, Netherlands
Katie Douglas, New Zealand
Peter Gallagher, UK
Gregor Hasler, Switzerland
Lars Kessing, Denmark
Hanne Kjaerstad, Denmark
Benny Lafer, Brazil
K. Eve Lewandowski, USA
Carlos Lopez-Jaramillo, Colombia
Anabel Martinez-Aran, Spain
Roger McIntyre, Canada
Richard Porter, New Zealand
Scot Purdon, Canada
Ayal Schaffer, Canada
Paul Stokes, UK
Tomiki Sumiyoshi, Japan
Ivan Torres, Canada
Dimosthenis Tsapekos, UK
Tamsyn Van Rheenen, Australia
Eduard Vieta, Spain
Lakshmi Yatham, Canada
Allan Young, UK
Jeff Zarp, Denmark
Task Force Updates
Publications:
2025
D.Tsapekos, M.Kalfas, J. M.Schandorff, et al., “Predicting Response to Pro-Cognitive Interventions in Mood Disorders: A Systematic Review by the International Society for Bipolar Disorders Targeting Cognition Task Force,” Acta Psychiatrica Scandinavica (2025): 1–28.
2024
Miskowiak KW, Obel ZK, Guglielmo R, et al. Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force. Bipolar Disord. 2024;26:216-239.
2022
Miskowiak KW, Seeberg I, Jensen MB, et al. Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force. Bipolar Disord. 2022;24:354–374.
2019
Miskowiak KW, Seeberg I, Kjaerstad HL, et al. Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force. Bipolar Disord. 2019;21:686–719.
Task Force Resources









